NEW YORK (GenomeWeb) – Genomic Health announced today that it expects preliminary revenue for the year ended December 31, 2015, to be between $285 million and $286 million, an approximate 4 percent increase over 2014's $275.7 million, but slightly below the company's 2015 guidance and below analysts' estimates for the year, which averaged $291.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.